Cardiovascular Therapeutic Drugs: Technologies and Global Markets
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
Antipsychotic Drugs: Technologies and Global Markets
Ubiquitin Proteosome Drugs: Cancer and Neurodegenerative Disorder Markets
Oncology Adjuvants: Technologies and Global Markets
The global ophthalmic market grew to $15.5 billion in 2009, showing resistance to the global recession. The sector will continue to grow through 2014 to $20.6 billion, a compound annual growth rate (CAGR) of 5.9%.
Total sales of drug-device combination products worldwide were valued at $12 billion in 2008. The overall market is increasing at a compound annual growth rate (CAGR) of 14.5% per year and thus sales are projected to reach $27 billion by 2014. Overall, sales in the U.S. represent about a third of total industry revenues.
The global cardiovascular market was valued at $140.7 billion in 2009, and is expected to continue to grow in 2010 to $144.5 billion by a compound annual growth rate (CAGR) of 2.7%. The sector will experience a sizable reduction in the early portion of the forecast period, and then slowly rise to a net small reduction by 2015 on a CAGR basis of -0.7%, to a figure of $139.8 billion.
Chapter-2: OPHTHALMIC THERAPEUTIC DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (PHM031C):
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
SCOPE OF REPORT 3
INTENDED AUDIENCE 4
INFORMATION SOURCES 5
RELATED BCC REPORTS 5
BCC ONLINE SERVICES 6
TABLE 1 GLOBAL OPHTHALMIC FORECAST BY DISEASE CLASS, THROUGH 2014 ($ MILLIONS) 7
FIGURE 1 GLOBAL OPHTHALMIC FORECAST BY DISEASE CLASS, 2008-2014 ($ MILLIONS) 8
HISTORY AND CURRENT STATE OF OPHTHA
Copyright©2010 PR Newswire.
All rights reserved